Skip to main content

Table 5 Hematopoetic parameters before, during and after adjuvant radiotherapy in 46 cases from 43 patients

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Hemoglobin Gram/dl
Before ART1 13.8/1.79/14.0 (mean/± SD/median)
During ART2 13.01/1.37/13.0 (mean/± SD/median)
After ART3 13.34/2.03/13.85 (mean/± SD/median)
Cases with Hemoglobin-decline during ART 3/46 (6.5%)
Leukocytes Thousand/μl
Before ART1 6.58/2.07/6.30 (mean/± SD/median)
During ART2 4.81/1.53/4.40 (mean/± SD/median)
After ART3 5.92/2.08/5.07 (mean/± SD/median)
Cases with Leukocytes-decline during ART 8/46 (17.4%)
Thrombocytes Thousand/μl
Before ART1 240.43/74.84/226.50 (mean/± SD/median)
During ART2 204.17/71.84/192.0 (mean/± SD/median)
After ART3 228.26/64.03/231.0 (mean/± SD/median)
Cases with Thrombocytes-decline during ART 2/46 (4.5%)
  1. ART = adjuvant radiotherapy.
  2. 1Mean 2.4 months before start of ART (SD: 2.5 months, median 1.78 months).
  3. 2Mean 0.80 months after start of ART (SD: 0.46 months, median 0.70 months).
  4. 3Mean 2.9 months after end of ART (SD: 3.15 months, median 1.57).